Question 1

How does Scilla bifolia work as a cardiac remedy?

Accepted Answer

Scilla bifolia contains cardiac glycosides, primarily scilliroside and glucoscillaren, which work by inhibiting sodium-potassium ATPase in cardiac cells. This mechanism increases intracellular calcium, strengthening cardiac contractions and slowing heart rate. Similar to digitalis, these compounds have positive inotropic effects on the heart. However, evidence for clinical use is limited (Level C), and the narrow therapeutic window makes raw plant use dangerous. Modern applications are primarily limited to homeopathic preparations due to toxicity concerns.

Question 2

Does Scilla bifolia interact with heart medications?

Accepted Answer

Yes, Scilla bifolia can interact dangerously with cardiac medications. The cardiac glycosides in this plant may have additive effects with digoxin, increasing toxicity risk. Concurrent use with diuretics, antiarrhythmics, or beta-blockers may cause electrolyte imbalances and arrhythmias. The plant's effects on heart rhythm and potassium levels make it contraindicated with most cardiovascular drugs. Patients taking any heart medication should avoid Scilla bifolia entirely. Evidence level C supports these theoretical interactions based on the known pharmacology of cardiac glycosides.

Question 3

What is the proper dosage for Scilla bifolia?

Accepted Answer

Due to significant cardiac toxicity, Scilla bifolia should only be used in homeopathic dilutions. There is no established safe dosage for the raw plant or crude extracts. Homeopathic preparations typically use extremely diluted forms (such as 6X or higher potencies) that minimize toxic risk. Self-medication with raw plant material is strongly discouraged. Evidence level C indicates limited modern clinical data, and the therapeutic window is extremely narrow. Professional guidance from a qualified homeopath is essential for any use.

Question 4

Is Scilla bifolia safe during pregnancy?

Accepted Answer

No, Scilla bifolia is contraindicated during pregnancy and breastfeeding. The cardiac glycosides present in the plant, particularly scilliroside, can cross the placenta and may cause fetal harm. The uterine-stimulating properties of cardiac glycosides pose additional risks of miscarriage or premature labor. Evidence level C supports this contraindication based on the known pharmacology of cardiac glycosides. Pregnant or nursing women should avoid all forms of Scilla bifolia, including homeopathic preparations, unless specifically prescribed by a qualified healthcare provider.

Question 5

What is Scilla bifolia used for in herbal medicine?

Accepted Answer

Scilla bifolia has been traditionally used as a diuretic, expectorant, and cardiac stimulant. Historically, it was employed for conditions involving fluid retention, respiratory congestion, and weak heart function. In homeopathy, dilute preparations are used for urinary and cardiac complaints. However, modern herbal use is extremely limited due to the plant's significant toxicity. Evidence level C indicates insufficient clinical data to support therapeutic claims. The presence of potent cardiac glycosides means raw plant use carries substantial risk of cardiac toxicity and is not recommended.

Question 6

Is Scilla bifolia toxic to humans?

Accepted Answer

Yes, Scilla bifolia is highly toxic to humans. The plant contains potent cardiac glycosides, including scilliroside, which can cause serious cardiac toxicity. Symptoms of poisoning include nausea, vomiting, cardiac arrhythmias, and potentially fatal heart block. The therapeutic dose is dangerously close to the toxic dose, giving this plant an extremely narrow safety margin. All parts of the plant contain toxic compounds. Evidence level C confirms toxicity based on pharmacological understanding of cardiac glycosides. Only homeopathic dilutions are considered for use, and even these require professional guidance.

Scilla bifolia

Sources et citations

Calculer une dose sûre de Scilla bifolia

Questions fréquentes

Résumé

Contexte

Composés actifs

Synthèse des preuves

Sources PubMed

Sources gouvernementales